β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cell
In conclusion, βOHB enhanced cisplatin-induced apoptosis via HDAC3/6 inhibition/survivin axis in HepG2 cells, which suggests that βOHB could be a new adjuvant agent for cisplatin chemotherapy.
Source: Journal of Pharmacological Sciences - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Drugs & Pharmacology | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Sports Medicine | Study | Urology & Nephrology